Jim Simons Ambrx Biopharma Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.41 - $4.54 $12,915 - $143,010
-31,500 Reduced 49.22%
32,500 $74,000
Q3 2022

Nov 14, 2022
BUY
$1.06 - $2.96 $56,180 - $156,880
53,000 Added 481.82%
64,000 $69,000
Q2 2022

Aug 12, 2022
SELL
$2.53 - $4.35 $29,347 - $50,459
-11,600 Reduced 51.33%
11,000 $29,000
Q1 2022

May 13, 2022
BUY
$4.07 - $9.0 $43,956 - $97,200
10,800 Added 91.53%
22,600 $93,000
Q4 2021

Feb 11, 2022
BUY
$8.11 - $13.91 $95,698 - $164,138
11,800 New
11,800 $107,000

Others Institutions Holding AMAM

# of Institutions
2
Shares Held
31.2K
Call Options Held
0
Put Options Held
0
View Full List

About Ambrx Biopharma Inc.

AMAM Quotes by TradingView
  • Ticker AMAM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,618,400
  • Market Cap $1.08B
  • Description
  • Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gas...
More about AMAM
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email